Subsidy Information and Financing Scheme MSHLRipretinib Tablet 50 mg Treatment of patients with advanced gastrointestinal stromal tumours (GIST) who have received prior... See all × MSHLRipretinib Tablet 50 mg Treatment of patients with advanced gastrointestinal stromal tumours (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.